Valby, Danmark, 2018-02-20 10:49 CET (GLOBE NEWSWIRE) -- Valby, Danmark, 20. februar 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort beslutningen om at udvide aktiekapitalen med DKK 43.340 som følge af udnyttelsen af medarbejder-warrants. Kapitalforhøjelsen tegnes uden fortegningsret for

Valby, Denmark, 2018-02-20 10:49 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 20 February 2018 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 43,340 as a consequence of the exercise of employee warrants.

Valby, Danmark, 2018-02-19 09:04 CET (GLOBE NEWSWIRE) -- Valby, Danmark, 19. februar 2018 — Der indkaldes herved til ordinær generalforsamling i H. Lundbeck A/S tirsdag den 20. marts 2018 kl. 10:00    Generalforsamlingen afholdes på selskabets adresse: H. Lundbeck A/S, Ottiliavej 9, 2500 Valby

Valby, Denmark, 2018-02-19 09:04 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 19 February 2018 — Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on:    Tuesday, 20 March 2018 at 10:00 am    The general meeting will be held at the offices of the Company at: H.

Valby, Denmark, 2018-02-07 07:53 CET (GLOBE NEWSWIRE) -- Annual Report 2017 for H. Lundbeck A/S.

Valby, Denmark, 2018-02-07 07:48 CET (GLOBE NEWSWIRE) --   HIGHLIGHTS Revenue reached DKK 17,234 million in 2017 representing an increase of 10% (12% in local currencies) compared to 2016 Revenue of Abilify Maintena ® increased by 19% to DKK 1,331 million (21% in local currencies) Revenue of

Nyt partnerskab med Vanderbilt Universitet giver Lundbeck eksklusive rettigheder til ny forskning i behandling af skizofreni.

New partnership with Vanderbilt University sees Lundbeck acquire an exclusive license to a research program aimed at a novel approach to treating schizophrenia.

Brintellix er nu godkendt til behandling af depression i Kina. Lancering forventes påbegyndt i andet kvartal af 2018.

Valby, Denmark, 2017-11-22 13:56 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 22 November 2017 — H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1.